Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials

详细信息    查看全文

• 作者：Qiang Wu (1)
  Hong-An Zhang (1)
  Shi-Long Liu (1)
  Tao Meng (1)
  Xin Zhou (1)
  Ping Wang (1)
  
  1. Department of Orthopaedics ; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine ; 314 An Shan Xi Road ; Nan Kai District ; Tianjin ; 300000 ; People鈥檚 Republic of China
  
• 关键词：Tranexamic acid ; TKA ; Meta ; analysis ; Blood loss ; Transfusion
• 刊名：European Journal of Orthopaedic Surgery & Traumatology
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：25
• 期：3
• 页码：525-541
• 全文大小：2,471 KB
• 参考文献：1. Park, JH, Rasouli, MR, Mortazavi, SM, Tokarski, AT, Maltenfort, MG, Parvizi, J (2013) Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am 95: pp. 1777-1783 2106/JBJS.L.01335" target="_blank" title="It opens in new window">CrossRef
  2. Banerjee, S, Kapadia, BH, Issa, K, McElroy, MJ, Khanuja, HS, Harwin, SF, Mont, MA (2013) Postoperative blood loss prevention in total knee arthroplasty. J Knee Surg 26: pp. 395-400 CrossRef
  3. Vielpeau, C (2012) Perioperative bleeding and early mortality in hip and knee surgery. Orthop Traumatol Surg Res 98: pp. 475-476 2012.06.002" target="_blank" title="It opens in new window">CrossRef
  4. Alshryda, S, Mason, J, Vaghela, M, Sarda, P, Nargol, A, Maheswaran, S, Tulloch, C, Anand, S, Logishetty, R, Stothart, B, Hungin, AP (2013) Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 95: pp. 1961-1968 2106/JBJS.L.00907" target="_blank" title="It opens in new window">CrossRef
  5. Schreiber, GB, Busch, MP, Kleinman, SH, Korelitz, JJ (1996) The risk of transfusion transmitted viral infections: the retrovirus epidemiology donor study. N Engl J Med 334: pp. 1685-1690 273342601" target="_blank" title="It opens in new window">CrossRef
  6. Mu帽oz, M, Cobos, A, Campos, A (2014) Low vacuum re-infusion drains after total knee arthroplasty: is there a real benefit?. Blood Transfus 12: pp. s173-s175
  7. Horstmann, W, Kuipers, B, Ohanis, D, Slappendel, R, Kollen, B, Verheyen, C (2014) Autologous re-transfusion drain compared with no drain in total knee arthroplasty: a randomised controlled trial. Blood Transfus 12: pp. s176-s181
  8. Perazzo, P, Vigan貌, M, Girolamo, L, Verde, F, Vinci, A, Banfi, G, Romagnoli, S (2013) Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation. Blood Transfus 11: pp. 370-376
  9. Hardy, JF, Desroches, J (1992) Natural and synthetic antifibrino-lytics in cardiac surgery. Can J Anaesth 39: pp. 353-365 CrossRef
  10. Abrishami, A, Chung, F, Wong, J (2009) Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis. Can J Anaesth 56: pp. 202-212 2630-008-9038-x" target="_blank" title="It opens in new window">CrossRef
  11. Ker, K, Edwards, P, Perel, P, Shakur, H, Roberts, I (2012) Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 344: pp. e3054 CrossRef
  12. Zhang, H, Chen, J, Chen, F, Que, W (2012) The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 20: pp. 1742-1752 CrossRef
  13. Aguilera, X, Martinez-Zapata, MJ, Bosch, A, Urr煤tia, G, Gonz谩lez, JC, Jordan, M, Gich, I, Maym贸, RM, Mart铆nez, N, Monllau, JC, Celaya, F, Fern谩ndez, JA (2013) Efficacy and safety of fibrin glue and tranexamic Acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J Bone Joint Surg Am 95: pp. 2001-2007 2106/JBJS.L.01182" target="_blank" title="It opens in new window">CrossRef
  14. Chareancholvanich, K, Siriwattanasakul, P, Narkbunnam, R, Pornrattanamaneewong, C (2012) Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial. BMC Musculoskelet Disord 13: pp. 124 2474-13-124" target="_blank" title="It opens in new window">CrossRef
  15. Georgiadis, AG, Muh, SJ, Silverton, CD, Weir, RM, Laker, MW (2013) A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 28: pp. 78-82 2013.03.038" target="_blank" title="It opens in new window">CrossRef
  16. Kim, TK, Chang, CB, Kang, YG, Seo, ES, Lee, JH, Yun, JH, Lee, SH (2014) Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 22: pp. 1870-1878 2492-1" target="_blank" title="It opens in new window">CrossRef
  17. Lee, SH, Cho, KY, Khurana, S, Kim, KI (2013) Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 21: pp. 2611-2617 2-2213-1" target="_blank" title="It opens in new window">CrossRef
  18. Martin, JG, Cassatt, KB, Kincaid-Cinnamon, KA, Westendorf, DS, Garton, AS, Lemke, JH (2014) Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty 29: pp. 889-894 2013.10.005" target="_blank" title="It opens in new window">CrossRef
  19. Pachauri A, Acharya KK, Tiwari AK (2013) The effect of tranexamic acid on hemoglobin levels during total knee arthroplasty. Am J Ther 21(5):366鈥?70
  20. Roy, SP, Tanki, UF, Dutta, A, Jain, SK, Nagi, ON (2012) Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 20: pp. 2494-2501 2-1942-5" target="_blank" title="It opens in new window">CrossRef
  21. Seo, JG, Moon, YW, Park, SH, Kim, SM, Ko, KR (2013) The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 21: pp. 1869-1874 2-2079-2" target="_blank" title="It opens in new window">CrossRef
  22. Abrishami, A (2010) Timing and volume of topical tranexamic acid administration for postoperative blood loss in total knee arthroplasty. Can J Anesth 51: pp. S142-S143
  23. Alvarez, JC, Santiveri, FX, Ramos, I, Vela, E, Puig, L, Escolano, F (2008) Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 48: pp. 519-525 2995.2007.01564.x" target="_blank" title="It opens in new window">CrossRef
  24. Benoni, G, Fredin, H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 78: pp. 434-440
  25. Camarasa, MA, Oll茅, G, Serra-Prat, M, Mart铆n, A, S谩nchez, M, Ric贸s, P, P茅rez, A, Opisso, L (2006) Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 96: pp. 576-582 CrossRef
  26. Charoencholvanich, K, Siriwattanasakul, P (2011) Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res 469: pp. 2874-2880 2" target="_blank" title="It opens in new window">CrossRef
  27. Ellis, MH, Fredman, B, Zohar, E, Ifrach, N, Jedeikin, R (2001) The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth 13: pp. 509-513 2-8180(01)00319-1" target="_blank" title="It opens in new window">CrossRef
  28. Engel, JM, Hohaus, T, Ruwoldt, R, Menges, T, J眉rgensen, I, Hempelmann, G (2001) Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 92: pp. 775-780 213/00000539-200103000-00041" target="_blank" title="It opens in new window">CrossRef
  29. Gautam, PL, Katyal, S, Yamin, M, Singh, A (2011) Effect of tranexamic acid on blood loss and transfusion requirement in total knee replacement in the Indian population: a case series. Indian J Anaesth 55: pp. 590-593 CrossRef
  30. Good, L, Peterson, E, Lisander, B (2003) Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 90: pp. 596-599 CrossRef
  31. Hiippala, ST, Strid, LJ, Wennerstrand, MI, Arvela, JV, Niemel盲, HM, M盲ntyl盲, SK, Kuisma, RP, Ylinen, JE (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84: pp. 839-844
  32. Hiippala, S, Strid, L, Wennerstrand, M, Arvela, V, M盲ntyl盲, S, Ylinen, J, Niemel盲, H (1995) Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 74: pp. 534-537 CrossRef
  33. Ishida, K, Tsumura, N, Kitagawa, A, Hamamura, S, Fukuda, K, Dogaki, Y, Kubo, S, Matsumoto, T, Matsushita, T, Chin, T, Iguchi, T, Kurosaka, M, Kuroda, R (2011) Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 35: pp. 1639-1645 264-010-1205-3" target="_blank" title="It opens in new window">CrossRef
  34. Jansen, AJ, Andreica, S, Claeys, M, D鈥橦aese, J, Camu, F, Jochmans, K (1999) Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 83: pp. 596-601 CrossRef
  35. Kakar, PN, Gupta, N, Govil, P, Shah, V (2009) Efficacy and safety of tranexamic acid in control of bleeding following TKR: a randomized clinical trial. Indian J Anaesth 53: pp. 667-671
  36. Maniar, RN, Kumar, G, Singhi, T, Nayak, RM, Maniar, PR (2012) Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 470: pp. 2605-2612 2-2310-y" target="_blank" title="It opens in new window">CrossRef
  37. McConnell, JS, Shewale, S, Munro, NA, Shah, K, Deakin, AH, Kinninmonth, AW (2012) Reducing blood loss in primary knee arthroplasty: a prospective randomised controlled trial of tranexamic acid and fibrin spray. Knee 19: pp. 295-298 2011.06.004" target="_blank" title="It opens in new window">CrossRef
  38. Molloy, DO, Archbold, HA, Ogonda, L, McConway, J, Wilson, RK, Beverland, DE (2007) Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br 89: pp. 306-309 2/0301-620X.89B3.17565" target="_blank" title="It opens in new window">CrossRef
  39. Onodera, T, Majima, T, Sawaguchi, N, Kasahara, Y, Ishigaki, T, Minami, A (2012) Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J Arthroplasty 27: pp. 105-108 2011.02.004" target="_blank" title="It opens in new window">CrossRef
  40. Orpen, NM, Little, C, Walker, G, Crawfurd, EJ (2006) Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 13: pp. 106-110 2005.11.001" target="_blank" title="It opens in new window">CrossRef
  41. Tanaka, N, Sakahashi, H, Sato, E, Hirose, K, Ishima, T, Ishii, S (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 83: pp. 702-705 2/0301-620X.83B5.11745" target="_blank" title="It opens in new window">CrossRef
  42. Veien, M, S酶rensen, JV, Madsen, F, Juelsgaard, P (2002) Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand 46: pp. 1206-1211 2002.461007.x" target="_blank" title="It opens in new window">CrossRef
  43. Wong, J, Abrishami, A, Beheiry, H, Mahomed, NN, Roderick Davey, J, Gandhi, R, Syed, KA, Muhammad Ovais Hasan, S, Silva, Y, Chung, F (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92: pp. 2503-2513 2106/JBJS.I.01518" target="_blank" title="It opens in new window">CrossRef
  44. Zhang, F, Gao, Z, Yu, J (2007) Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21: pp. 1302-1304
  45. Zohar, E, Ellis, M, Ifrach, N, Stern, A, Sapir, O, Fredman, B (2004) The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 99: pp. 1679-1683 213/01.ANE.0000136770.75805.19" target="_blank" title="It opens in new window">CrossRef
  46. Tan, J, Chen, H, Liu, Q, Chen, C, Huang, W (2013) A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res 184: pp. 880-887 2013.03.099" target="_blank" title="It opens in new window">CrossRef
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Surgical Orthopedics
  Traumatic Surgery
  
• 出版者：Springer Paris
• ISSN：1432-1068

文摘

Background Tranexamic acid (TXA) is well established as a versatile intraarticular and intravenous (IV) antifibrinolytic agent that has been successfully used to control bleeding after total knee arthroplasty (TKA). The present meta-analysis aimed at assessing the effectiveness and safety of TXA in reducing blood loss and transfusion in TKA. Methods We searched the PubMed, Medline, Embase, Cochrane Central Register of Controlled Trials, and Google Scholar databases from 1966 to December 2013. Only randomized controlled trials (RCTs) were included in the present study. Two independent reviewers identified the eligible studies, assessed their methodological quality, and extracted data. The data were using fixed-effects or random-effects models with standard mean differences and risk ratios for continuous and dichotomous variables, respectively. Subgroup analysis was performed according to the IV or intraarticular administration of TXA. Results Thirty-four RCTs encompassing 2,594 patients met the inclusion criteria for our meta-analysis. Our meta-analysis indicated that when compared with the control group, the IV or intraarticular use of TXA significantly reduced total blood loss, postoperative blood loss, Hb loss, and transfusion rate as well as blood units transfused per patient after primary TKA, but did not reduce intraoperative blood loss. No significant difference in deep vein thrombosis (DVT), pulmonary embolism, or other adverse events among the study groups. Conclusions IV or intraarticular use of TXA for patients undergoing TKA is effective and safe for the reduction blood loss and blood transfusion requirements, yet does not increase the risk of postoperative DVT. Level of evidence Level II.